Latest & greatest articles for cannabis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cannabis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cannabis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cannabis

141. Association between marijuana exposure and pulmonary function over 20 years. Full Text available with Trip Pro

Association between marijuana exposure and pulmonary function over 20 years. Marijuana smoke contains many of the same constituents as tobacco smoke, but whether it has similar adverse effects on pulmonary function is unclear.To analyze associations between marijuana (both current and lifetime exposure) and pulmonary function.The Coronary Artery Risk Development in Young Adults (CARDIA) study, a longitudinal study collecting repeated measurements of pulmonary function and smoking over 20 years (...) (March 26, 1985-August 19, 2006) in a cohort of 5115 men and women in 4 US cities. Mixed linear modeling was used to account for individual age-based trajectories of pulmonary function and other covariates including tobacco use, which was analyzed in parallel as a positive control. Lifetime exposure to marijuana joints was expressed in joint-years, with 1 joint-year of exposure equivalent to smoking 365 joints or filled pipe bowls.Forced expiratory volume in the first second of expiration (FEV(1

2012 JAMA

142. What is the Accuracy of Screening Instruments for Alcohol and Cannabis Misuse Disorders Among Adolescents and Young Adults in the Emergency Department?

What is the Accuracy of Screening Instruments for Alcohol and Cannabis Misuse Disorders Among Adolescents and Young Adults in the Emergency Department? Systematic Review Snapshot TAKE-HOME MESSAGE The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 2-item screen for alcohol misuse and 1-item Diagnostic Interview Schedule for Children question for cannabis abuse are simple tools that could be adopted for emergency department (ED) use; however, their performance (...) and studies in progress. STUDY SELECTION Studies were included if the in- strument focused on detecting alcohol and other drug misuse in patients aged 21 years or younger in the ED and if the authors at- tempted to establish the reliabil- ity, validity, and accuracy of these instruments. Each study was screened by at least 2 of 4 re- viewers; the speci?c method for dealing with discrepancies was not described. What Is the Accuracy of Screening Instruments for Alcohol and Cannabis Misuse Disorders Among

2012 Annals of Emergency Medicine Systematic Review Snapshots

143. Extract from Cannabis sativa - Benefit assessment according to § 35a Social Code Book V

Waffenschmidt ? Beate Wieseler Keywords: cannabinoids, multiple sclerosis, benefit assessment 2 Due to legal data protection regulations, employees have the right not to be named. Extract of dossier assessment A12-01 Version 1.0 Extract from Cannabis sativa – Benefit assessment acc. to § 35a SGB V 29.03.2012 Institute for Quality and Efficiency in Health Care (IQWiG) - iii - Table of contents List of abbreviations v 2 Benefit assessment 1 2.1 Executive summary of the benefit assessment 1 2.2 Research (...) Extract from Cannabis sativa - Benefit assessment according to § 35a Social Code Book V Extract 1 Translation of Sections 2.1 to 2.6 of the dossier assessment (“Extrakt aus Cannabis Sativa – Nutzenbewertung gemäß § 35a SGB V” (Version 1.0; Status: 29.03.2012). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract from Cannabis sativa – Benefit assessment

2012 Institute for Quality and Efficiency in Healthcare (IQWiG)

144. Delusional-like experiences are more common in those with cannabis dependence disorder, very early-onset alcohol use or dependence disorders, and daily smokers

Delusional-like experiences are more common in those with cannabis dependence disorder, very early-onset alcohol use or dependence disorders, and daily smokers Delusional-like experiences are more common in those with cannabis dependence disorder, very early-onset alcohol use or dependence disorders, and daily smokers | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any (...) time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Delusional-like experiences are more common in those with cannabis

2012 Evidence-Based Mental Health

145. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. Full Text available with Trip Pro

Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. To determine whether use of cannabis in adolescence increases the risk for psychotic outcomes by affecting the incidence and persistence of subclinical expression of psychosis in the general population (that is, expression of psychosis below the level required for a clinical diagnosis).Analysis of data from a prospective population based cohort study in Germany (early (...) developmental stages of psychopathology study).Population based cohort study in Germany.1923 individuals from the general population, aged 14-24 at baseline.Incidence and persistence of subthreshold psychotic symptoms after use of cannabis in adolescence. Cannabis use and psychotic symptoms were assessed at three time points (baseline, T2 (3.5 years), T3 (8.4 years)) over a 10 year follow-up period with the Munich version of the composite international diagnostic interview (M-CIDI).In individuals who had

2011 BMJ

146. Grass pollen allergen Phleum pratense (Grazax®) in allergic rhinitis and conjunctivitis induced by grass pollen

Grass pollen allergen Phleum pratense (Grazax®) in allergic rhinitis and conjunctivitis induced by grass pollen 2011. DAR No 2. Grass pollen allergen Phleum pratense (Grazax®) in allergic rhinitis and conjunctivitis induced by grass pollen - navarra.es | Euskara | Français | English Use the search tool! Search engine : : : : : : DAR No 2. Grass pollen allergen Phleum pratense (Grazax®) in allergic rhinitis and conjunctivitis induced by grass pollen DAR No 2. Grass pollen allergen Phleum (...) pratense (Grazax®) in allergic rhinitis and conjunctivitis induced by grass pollen Content tools Share it A long and expensive preventive treatment with very modest results Pollen extract from Phleum pratense (Timothy grass) has been introduced in the market for the treatment of allergic rhinitis and conjunctivitis caused by a grass pollen when clinically relevant symptoms are present and specific tests confirm the origin of the allergy. Four clinical trials studying this agent have been published

2011 Drug and Therapeutics Bulletin of Navarre (Spain)

147. One-year follow-up of clinical and inflammatory parameters in children allergic to grass pollen receiving high-dose ultrarush sublingual immunotherapy. (Abstract)

One-year follow-up of clinical and inflammatory parameters in children allergic to grass pollen receiving high-dose ultrarush sublingual immunotherapy. In a previous double-blind placebo-controlled study, we analyzed a high-dose sublingual immunotherapy (SLIT) ultrarush protocol in asthmatic children monosensitized to grass pollen. In the present open-label study, we assessed the effect of SLIT on symptom score and nonspecific bronchial hyperreactivity in the same cohort followed for 1 (...) and medication score remained unchanged in the group who continued SLIT. We also observed further significant improvement in the results of the methacholine challenge test during the third year of treatment.High-dose ultrarush SLIT reduced the severity of allergic symptoms in the first 2 grass pollen seasons but continuously improved bronchial hyperreactivity in children with asthma, suggesting that SLIT should be continued despite the lack of further improvement in clinical symptoms.

2011 Journal of investigational allergology & clinical immunology

148. Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials

Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

149. Incident cannabis use in adolescents and young adults is associated with an increased risk of developing psychotic symptoms

Incident cannabis use in adolescents and young adults is associated with an increased risk of developing psychotic symptoms Incident cannabis use in adolescents and young adults is associated with an increased risk of developing psychotic symptoms | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Incident cannabis use in adolescents and young adults is associated with an increased risk of developing psychotic symptoms Article Text

2011 Evidence-Based Mental Health

150. Smoking Marijuana in Relation to Periodontal Disease

) (Behavioral Science) Keywords Marijuana, Cannabis, Periodontal Disease ID# 843 Date of submission: 04/01/2011 E-mail ara@livemail.uthscsa.edu Author Sharmin Ara Co-author(s) Co-author(s) e-mail Faculty mentor/Co-author Archie Jones, DDS, MBA Faculty mentor/Co-author e-mail JonesA@uthscsa.edu Basic Science Rationale (Mechanisms that may account for and/or explain the clinical question, i.e. is the answer to the clinical question consistent with basic biological, physical and/or behavioral science (...) Smoking Marijuana in Relation to Periodontal Disease UTCAT843, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Smoking Marijuana In Relation To Periodontal Disease Clinical Question In patients with good periodontal health, does smoking marijuana increase the risk for developing periodontal disease as compared to non-smokers? Clinical Bottom Line Smoking marijuana does not increase risk for developing periodontal

2011 UTHSCSA Dental School CAT Library

151. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. Full Text available with Trip Pro

Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. The extant literature on the treatment of pediatric obsessive-compulsive disorder (OCD) indicates that partial response to serotonin reuptake inhibitors (SRIs) is the norm and that augmentation with short-term OCD-specific cognitive behavior therapy (CBT) may provide additional benefit.To examine the effects

2011 JAMA Controlled trial quality: predicted high

152. California annual grass invaders: the drivers or passengers of change? Full Text available with Trip Pro

California annual grass invaders: the drivers or passengers of change? The dominance of invasive species is often assumed to reflect their competitive superiority over displaced native species. However, invasive species may be abundant because of their greater tolerance to anthropogenic impacts accompanying their introduction. Thus, invasive species can either be the drivers or passengers of change.We distinguish between these two possibilities in California grasslands currently dominated (...) by Mediterranean annuals (exotics) and subjected to livestock grazing since European settlement. We focused on native annual grasses and forbs, an understudied species-rich component of the California flora, and Mediterranean annual grasses, currently dominant and among the first non-native plants introduced to the area.We established a field experiment with fenced and unfenced blocks in a cattle pasture. We measured concentrations of limiting resources (nitrogen, phosphorus, light and soil moisture

2010 The Journal of ecology

153. Cannabinoid Hyperemesis: High on the Differential for Intractable Vomiting

. The largest study of cannabinoid hyperemesis to date was the landmark report by Allen et al in 2004 in an area of Southern Australia where marijuana use is largely decriminalized. The report tracked 10 patients who presented with cyclic vomiting after 3 to 27 years of cannabis abuse and no other history of drug abuse. All but one displayed compulsive hot water bathing; the remaining patient had only experienced his symptoms for 6 months, and the authors theorize that he had not yet learned to associate (...) interventions. There are, however, several obstacles to effective diagnosis: First, the legal status of marijuana makes eliciting an accurate drug history challenging. Second, the bizarre hot water bathing is likely often attributed to psychological conditions such as obsessive-compulsive behavior. Third, the knowledge of the anti-emetic effects of cannabis likely disguises cases of cannabinoid hyperemesis, leading to the erroneous belief that cannabis is treating cyclic vomiting rather than causing

2010 Clinical Correlations

154. Cannabis and suicide: longitudinal study Full Text available with Trip Pro

Cannabis and suicide: longitudinal study Some studies suggest that cannabis use is associated with suicidal ideation, but no detailed longitudinal study has examined suicide as an outcome.To examine the association between cannabis use and completed suicide.A longitudinal study investigated 50 087 men conscripted for Swedish military service, with cannabis use measured non-anonymously at conscription. Suicides during 33 years of follow-up were identified by linkage with the National Cause (...) of Death Register.There were 600 (1.2% of cohort) suicides or deaths from undetermined causes. Cannabis use was associated with an increased risk of suicide (crude OR for 'ever use' 1.62, 95% CI 1.28-2.07), but this association was eliminated after adjustment for confounding (adjusted OR = 0.88, 95% CI 0.65-1.20).Although there was a strong association between cannabis use and suicide, this was explained by markers of psychological and behavioural problems. These results suggest that cannabis use

2010 EvidenceUpdates

155. Cannabis and mental health management in primary care

in their life, with around 9% reporting use in the past 12 months. 1 Over the past few decades, the proportion of young people who have used cannabis has steadily increased while the age of first use has declined. 2 An earlier onset of use increases the risk for subsequent dependence, while regular use during adolescence predicts later use of other illicit drugs, underperformance in school and mental health problems. 3 Cannabinoids there are more than 60 different cannabinoids found within Cannabis sativa (...) , although they vary considerably in the extent to which they are psychoactive. the two most abundant naturally occurring cannabinoids are ?9-tetrahydrocannabinol (thc) and cannabidiol (cBD), but these have markedly different (and almost opposing) effects. While thc is psychotomimetic and accounts for the ‘high’ associated with cannabis use, cBD has been found to be anxiolytic and to have antipsychotic properties. 4 Variations in the ratio of these two cannabinoids in illicit cannabis supplies

2010 The Royal Australian College of General Practitioners

156. Review: short-term medical use of cannabis increases risk of non-serious adverse effects

Review: short-term medical use of cannabis increases risk of non-serious adverse effects Review: short-term medical use of cannabis increases risk of non-serious adverse effectsCommentary | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: short-term medical use of cannabis increases risk of non-serious adverse effectsCommentary Article Text Treatment Review: short-term medical use of cannabis increases risk of non-serious adverse effects

2010 Evidence-Based Nursing

157. Review: pharmacological and psychological interventions decrease cannabis use in people with depressive and psychotic disorders in the short term

Review: pharmacological and psychological interventions decrease cannabis use in people with depressive and psychotic disorders in the short term Review: pharmacological and psychological interventions decrease cannabis use in people with depressive and psychotic disorders in the short term | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about (...) how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: pharmacological and psychological interventions decrease cannabis use in people

2010 Evidence-Based Mental Health

158. Estimates of how many cannabis users need to be prevented in order to prevent one case of schizophrenia

Estimates of how many cannabis users need to be prevented in order to prevent one case of schizophrenia Estimates of how many cannabis users need to be prevented in order to prevent one case of schizophrenia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Estimates of how many cannabis users need to be prevented in order to prevent one case of schizophrenia Article Text Aetiology Estimates of how many cannabis users need

2010 Evidence-Based Mental Health

159. A systematic review of school-based marijuana and alcohol prevention programs targeting adolescents aged 10-15 Full Text available with Trip Pro

A systematic review of school-based marijuana and alcohol prevention programs targeting adolescents aged 10-15 A systematic review of school-based marijuana and alcohol prevention programs targeting adolescents aged 10-15 A systematic review of school-based marijuana and alcohol prevention programs targeting adolescents aged 10-15 Lemstra M, Bennett N, Nannapaneni U, Neudorf C, Warren L, Kershaw T, Scott C CRD summary This review concluded that comprehensive intervention programmes (...) that included anti-drug information with refusal skills, self-management skills and social skills training were the most effective programmes for long-term reduction of marijuana and alcohol use in adolescents (10 to 15 years). Variation between studies and the risk of missing data suggested that the author's conclusions may not be reliable. Authors' objectives To determine the effectiveness of school-based marijuana and alcohol prevention programmes for the prevention of marijuana and alcohol use

2010 DARE.

160. A meta-analytic review of school-based prevention for cannabis use

A meta-analytic review of school-based prevention for cannabis use Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.